Discover 626 paid clinical trials in Nebraska. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Nebraska provides a variety of paid research opportunities for both healthy volunteers and individuals with specific medical concerns. Research institutions in Omaha, Lincoln, and Bellevue are recruiting participants, offering access to advanced treatments and dedicated medical care.
Filter
1
Filter results
Results: 626
The Pediatric Anesthesia Quality Improvement Project
for
Surgery, Anesthesia, Children
Location: Boston MA, New York NY, Philadelphia PA, Wilmington DE,
Sponsor: The Society for Pediatric Anesthesia
Sex: All
Age: 0 - 21
Code: NCT00674388
Recruiting
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
for
Relapsed Hematologic Malignancy,
Location: Boston MA, New York NY, Durham NC, Buffalo NY,
Sponsor: Curis, Inc.
Sex: All
Age: 18+
Code: NCT03328078
Phase1, Phase2, Recruiting
Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
for
Glioma, Glioblastoma Multiforme
Location: Rochester MN, Omaha NE
Sponsor: Aveta Biomics, Inc.
Sex: All
Age: 19+
Code: NCT06011109
Phase1, Phase2, Recruiting
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Location: New York NY, Philadelphia PA, Durham NC, Miami FL,
Sponsor: Fate Therapeutics
Sex: All
Age: 12 - 70
Code: NCT06308978
Phase1, Recruiting
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: Boston MA, New Haven CT, Stony Brook NY,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06001788
Phase1, Recruiting
Adaptive and Individualized AAC Phase II
for
Communication Disorders
Location: Omaha NE
Sponsor: Altec Inc.
Sex: All
Age: 6+
Code: NCT06337188
Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
for
Type 1 Diabetes Mellitus With Hypoglycemia
Location: New Haven CT, Long Island City NY, New York NY,
Sponsor: Zucara Therapeutics Inc.
Sex: All
Age: 18 - 70+
Code: NCT05762107
Phase2, Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
for
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen,
Location: Boston MA, New Haven CT, New York NY, Montreal,
Sponsor: Servier Bio-Innovation LLC
Sex: All
Age: 18+
Code: NCT06127407
Phase3, Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT03959085
Phase3, Recruiting
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
for
Embryonal Rhabdomyosarcoma,
Location: Halifax, Scarborough ME, Boston MA, Providence RI,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT05304585
Phase3, Recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Boston MA, Burlington MA, Norfolk MA, Hartford CT,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06433752
Recruiting
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
for
Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8,